Who is sponsoring NCT03113539?

NCT03113539 is sponsored by Université de Sherbrooke.

What condition does NCT03113539 study?

NCT03113539 studies Ascendant Aortic Aneurysm.

Is NCT03113539 still recruiting?

NCT03113539 is currently completed. Last updated 18 July 2019.

Last reviewed 2019-07-18 · How we verify

NCT03113539

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low-dose Gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.

Completed NA Last updated 18 July 2019

What this trial tests

NA trial testing Modified Low-dose, EKG-gated CT without contrast for the evaluation of aortic aneurysm in Ascendant Aortic Aneurysm in 66 participants. Completed in 30 May 2019.

Timeline

12 April 2017

Primary endpoint
30 April 2019

30 May 2019

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	66
Start date	12 April 2017
Primary completion	30 April 2019
Estimated completion	30 May 2019
Sites	1 location across Canada

Drugs / interventions tested

Modified Low-dose, EKG-gated CT without contrast for the evaluation of aortic aneurysm

Conditions studied

Ascendant Aortic Aneurysm — all drugs for Ascendant Aortic Aneurysm →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

Adults 60 to 100, any sex, with Ascendant Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will demonstrate the validity of measurements with a low-dose, EKG-gated CT without contrast in the ascending aorta evaluation, compared with the current Angio-CT measurements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Université de Sherbrooke trials

Trials by the same sponsor.

NCT07524764 — Female Reproductive Health in Canadian Armed Forces · not yet recruiting
NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
NCT07396857 — The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting · NA · recruiting
NCT07122531 — Recovery With Exogenous Ketones and Antipsychotics · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03113539 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Sherbrooke
Last refreshed: 18 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03113539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing